BRPI0709057B8 - veículo mucoso bioadesivo de lenta liberação, método para preparar um veículo mucoso bioadesivo de lenta liberação, e, uso do veículo mucoso bioadesivo de lenta liberação - Google Patents
veículo mucoso bioadesivo de lenta liberação, método para preparar um veículo mucoso bioadesivo de lenta liberação, e, uso do veículo mucoso bioadesivo de lenta liberaçãoInfo
- Publication number
- BRPI0709057B8 BRPI0709057B8 BRPI0709057A BRPI0709057A BRPI0709057B8 BR PI0709057 B8 BRPI0709057 B8 BR PI0709057B8 BR PI0709057 A BRPI0709057 A BR PI0709057A BR PI0709057 A BRPI0709057 A BR PI0709057A BR PI0709057 B8 BRPI0709057 B8 BR PI0709057B8
- Authority
- BR
- Brazil
- Prior art keywords
- vehicle
- slow
- mucous
- bioadhesive
- release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06290480A EP1837020A1 (en) | 2006-03-24 | 2006-03-24 | Mucosal bioadhesive slow release carrier for delivering active principles |
EP06290480.0 | 2006-03-24 | ||
PCT/IB2007/001662 WO2007110778A2 (en) | 2006-03-24 | 2007-03-23 | Mucosal bioadhesive slow release carrier for delivering active principles |
Publications (4)
Publication Number | Publication Date |
---|---|
BRPI0709057A2 BRPI0709057A2 (pt) | 2011-06-28 |
BRPI0709057B1 BRPI0709057B1 (pt) | 2020-06-30 |
BRPI0709057B8 true BRPI0709057B8 (pt) | 2021-02-23 |
BRPI0709057C1 BRPI0709057C1 (pt) | 2021-05-25 |
Family
ID=36889131
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0709057A BRPI0709057C1 (pt) | 2006-03-24 | 2007-03-23 | veículo mucoso bioadesivo de lenta liberação, método para preparar um veículo mucoso bioadesivo de lenta liberação, e, uso do veículo mucoso bioadesivo de lenta liberação |
Country Status (27)
Country | Link |
---|---|
US (5) | US20090169511A1 (pt) |
EP (3) | EP1837020A1 (pt) |
JP (1) | JP5242548B2 (pt) |
KR (1) | KR101335185B1 (pt) |
CN (1) | CN101410092B (pt) |
AR (1) | AR060085A1 (pt) |
AT (1) | ATE446743T1 (pt) |
AU (1) | AU2007231029B2 (pt) |
BR (1) | BRPI0709057C1 (pt) |
CA (1) | CA2647123C (pt) |
CY (1) | CY1109723T1 (pt) |
DE (1) | DE602007002996D1 (pt) |
DK (1) | DK1998750T3 (pt) |
ES (1) | ES2335712T3 (pt) |
HK (1) | HK1121692A1 (pt) |
HR (1) | HRP20100039T1 (pt) |
IL (1) | IL193987A (pt) |
ME (1) | ME01180B (pt) |
MX (1) | MX2008012186A (pt) |
MY (1) | MY150072A (pt) |
PL (1) | PL1998750T3 (pt) |
PT (1) | PT1998750E (pt) |
RS (1) | RS51342B (pt) |
RU (1) | RU2420267C2 (pt) |
SI (1) | SI1998750T1 (pt) |
WO (1) | WO2007110778A2 (pt) |
ZA (1) | ZA200807883B (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1837020A1 (en) | 2006-03-24 | 2007-09-26 | Bioalliance Pharma | Mucosal bioadhesive slow release carrier for delivering active principles |
EP2165706A1 (en) * | 2008-09-18 | 2010-03-24 | BioAlliance Pharma | Treating Inflammatory Pain in Mucosa of the Oral Cavity Using Mucosal Prolonged Release Bioadhesive Therapeutic Carriers. |
EP2509586B1 (en) | 2009-12-09 | 2018-05-02 | Vectans Pharma | Mucoadhesive buccal tablets for the treatment of orofacial herpes |
EP2335690A1 (en) | 2009-12-09 | 2011-06-22 | BioAlliance Pharma | Mucoadhesive buccal tablets for the treatment of orofacial herpes |
US8592434B2 (en) * | 2009-12-09 | 2013-11-26 | Bioalliance Pharma Sa | Mucoadhesive buccal tablets for the treatment of orofacial herpes |
CA2841851A1 (en) * | 2011-07-15 | 2013-01-24 | Femalon S.P.R.L. | Composition and method for treating hpv |
KR101406106B1 (ko) * | 2011-12-19 | 2014-06-13 | 동국제약 주식회사 | 국소 투여용 지속형 치주염 치료제 조성물 |
CN108904460A (zh) * | 2012-02-19 | 2018-11-30 | 奥拉黑尔斯公司 | 用于口腔粘附圆片的碱化金合欢树胶粘合剂 |
KR20170141774A (ko) * | 2015-04-29 | 2017-12-26 | 포어사이트 바이오쎄라퓨틱스, 인코퍼레이티드 | 항바이러스 및 항염증 치료제의 치료 조합물 |
RU2636173C1 (ru) * | 2016-08-03 | 2017-11-21 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СтГМУ Минздрава России) | Способ лечения хронического генерализованного пародонтита средней степени тяжести в стадии обострения |
RU2636185C1 (ru) * | 2016-08-03 | 2017-11-21 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СтГМУ Минздрава России) | Способ лечения хронического генерализованного катарального гингивита в стадии обострения |
BR102018008324A2 (pt) * | 2018-04-25 | 2019-11-05 | Laboratorios Ferring Ltda | composição farmacêutica de uso tópico e processo de fabricação de composição farmacêutica de uso tópico |
CA3099119A1 (en) * | 2018-04-30 | 2019-11-07 | Perfect Day, Inc. | Recombinant milk protein polymers |
WO2020150460A1 (en) * | 2019-01-18 | 2020-07-23 | Milne Iii Donald A | Micronized aspirin formulation |
CN111803468B (zh) * | 2020-06-23 | 2022-12-23 | 黑龙江天龙药业有限公司 | 一种靶向、缓释、成膜抑制病毒、细菌的鼻腔喷膜剂及其制备方法 |
CN115463102B (zh) * | 2022-09-26 | 2023-11-24 | 湖北科益药业股份有限公司 | 一种阿昔洛韦片剂及其制备方法 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58210007A (ja) | 1982-06-02 | 1983-12-07 | Takeda Chem Ind Ltd | 上部「あ」 |
DE3320583A1 (de) | 1983-06-08 | 1984-12-13 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung |
US4849229A (en) | 1984-03-26 | 1989-07-18 | Forest Laboratories, Inc. | Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants |
DE3433239A1 (de) | 1984-09-11 | 1986-03-20 | Bayer Ag, 5090 Leverkusen | Feste arzneizubereitung enthaltend nitrendipin und verfahren zu ihrer herstellung |
IL85538A (en) * | 1987-02-27 | 1991-09-16 | Lilly Co Eli | Sustained release matrix tablet formulations containing hydrophilic and enteric polymers |
US4792452A (en) | 1987-07-28 | 1988-12-20 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
US4915948A (en) | 1987-08-31 | 1990-04-10 | Warner-Lambert Company | Tablets having improved bioadhesion to mucous membranes |
US5160737A (en) | 1988-05-03 | 1992-11-03 | Perio Products Ltd. | Liquid polymer composition, and method of use |
US5330746A (en) | 1988-05-03 | 1994-07-19 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Dental varnish composition, and method of use |
US5116603A (en) | 1989-01-31 | 1992-05-26 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Oral antifungal preventative, and method of use |
NZ234587A (en) * | 1989-08-04 | 1991-11-26 | Mcneil Ppc Inc | A chewable pharmaceutical tablet of compressed coated granules |
EP0451433B1 (en) | 1990-04-12 | 1996-10-23 | Janssen Pharmaceutica N.V. | Composition of a bioadhesive sustained delivery carrier for drug administration |
FR2665357B1 (fr) | 1990-07-31 | 1995-03-31 | Aiache Jean Marc | Procede de preparation d'une forme galenique bio-adhesive et forme galenique ainsi preparee. |
GB9318641D0 (en) | 1993-09-08 | 1993-10-27 | Edko Trading Representation | Compositions |
DK0752855T3 (da) | 1994-03-30 | 2000-01-03 | Gs Dev Ab | Anvendelse af fedtsyreestere som bioadhæsive substanser |
SI9500173B (sl) * | 1995-05-19 | 2002-02-28 | Lek, | Trofazna farmacevtska oblika s konstantnim in kontroliranim sproščanjem amorfne učinkovine za enkrat dnevno aplikacijo |
US5766620A (en) | 1995-10-23 | 1998-06-16 | Theratech, Inc. | Buccal delivery of glucagon-like insulinotropic peptides |
US5919489A (en) | 1995-11-01 | 1999-07-06 | Abbott Laboratories | Process for aqueous granulation of clarithromycin |
SI0869772T1 (en) | 1995-12-27 | 2002-04-30 | Janssen Pharmaceutica N.V. | Bioadhesive solid dosage form |
AU6853498A (en) | 1997-04-22 | 1998-11-13 | Nippon Kayaku Kabushiki Kaisha | Flutamide preparations and method for manufacturing the same |
US6248358B1 (en) | 1998-08-25 | 2001-06-19 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets and methods of making and using the same |
SE9803239D0 (sv) | 1998-09-24 | 1998-09-24 | Diabact Ab | Composition for the treatment of acute pain |
US6210699B1 (en) * | 1999-04-01 | 2001-04-03 | Watson Pharmaceuticals, Inc. | Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity |
US20030224058A1 (en) * | 2002-05-24 | 2003-12-04 | Elan Pharma International, Ltd. | Nanoparticulate fibrate formulations |
WO2002041876A1 (en) * | 2000-11-22 | 2002-05-30 | Lupin Limited | Pharmaceutical composition for controlled release of an active ingredient |
US20020143058A1 (en) * | 2001-01-24 | 2002-10-03 | Taro Pharmaceutical Inductries Ltd. | Process for preparing non-hygroscopic sodium valproate composition |
EP1390015A1 (en) * | 2001-05-31 | 2004-02-25 | Cima Labs Inc. | Taste-masking of highly water-soluble drugs |
FR2827517B1 (fr) * | 2001-07-23 | 2003-10-24 | Bioalliance Pharma | Systemes therapeutiques bioadhesifs a liberation prolongee |
KR20050096950A (ko) * | 2003-01-31 | 2005-10-06 | 오렉쏘 에이비 | 신속-작용 약학 조성물 |
EP1837020A1 (en) | 2006-03-24 | 2007-09-26 | Bioalliance Pharma | Mucosal bioadhesive slow release carrier for delivering active principles |
-
2006
- 2006-03-24 EP EP06290480A patent/EP1837020A1/en not_active Withdrawn
-
2007
- 2007-03-23 WO PCT/IB2007/001662 patent/WO2007110778A2/en active Search and Examination
- 2007-03-23 CA CA2647123A patent/CA2647123C/en active Active
- 2007-03-23 DK DK07734862.1T patent/DK1998750T3/da active
- 2007-03-23 SI SI200730144T patent/SI1998750T1/sl unknown
- 2007-03-23 CN CN2007800105745A patent/CN101410092B/zh active Active
- 2007-03-23 RS RSP-2010/0010A patent/RS51342B/en unknown
- 2007-03-23 AT AT07734862T patent/ATE446743T1/de active
- 2007-03-23 AR ARP070101207A patent/AR060085A1/es not_active Application Discontinuation
- 2007-03-23 MY MYPI20083748A patent/MY150072A/en unknown
- 2007-03-23 ME MEP-2010-13A patent/ME01180B/me unknown
- 2007-03-23 KR KR1020087025055A patent/KR101335185B1/ko active IP Right Grant
- 2007-03-23 AU AU2007231029A patent/AU2007231029B2/en active Active
- 2007-03-23 MX MX2008012186A patent/MX2008012186A/es active IP Right Grant
- 2007-03-23 US US12/225,470 patent/US20090169511A1/en not_active Abandoned
- 2007-03-23 ES ES07734862T patent/ES2335712T3/es active Active
- 2007-03-23 BR BRPI0709057A patent/BRPI0709057C1/pt active IP Right Grant
- 2007-03-23 PL PL07734862T patent/PL1998750T3/pl unknown
- 2007-03-23 EP EP07734862A patent/EP1998750B1/en active Active
- 2007-03-23 DE DE602007002996T patent/DE602007002996D1/de active Active
- 2007-03-23 PT PT07734862T patent/PT1998750E/pt unknown
- 2007-03-23 EP EP09174249A patent/EP2216017A1/en not_active Withdrawn
- 2007-03-23 JP JP2009502254A patent/JP5242548B2/ja active Active
- 2007-03-23 RU RU2008139869/15A patent/RU2420267C2/ru active
-
2008
- 2008-09-09 IL IL193987A patent/IL193987A/en active IP Right Grant
- 2008-09-12 ZA ZA2008/07883A patent/ZA200807883B/en unknown
-
2009
- 2009-02-26 HK HK09101825.0A patent/HK1121692A1/xx unknown
-
2010
- 2010-01-11 CY CY20101100033T patent/CY1109723T1/el unknown
- 2010-01-21 HR HR20100039T patent/HRP20100039T1/hr unknown
- 2010-02-17 US US12/707,369 patent/US8211466B2/en active Active
-
2012
- 2012-06-29 US US13/539,029 patent/US20120326350A1/en not_active Abandoned
- 2012-08-02 US US13/565,653 patent/US8747896B2/en active Active
-
2013
- 2013-07-16 US US13/943,504 patent/US8791127B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0709057B8 (pt) | veículo mucoso bioadesivo de lenta liberação, método para preparar um veículo mucoso bioadesivo de lenta liberação, e, uso do veículo mucoso bioadesivo de lenta liberação | |
BR112017020015A2 (pt) | moléculas tendo utilidade pesticida, e intermediários, composições e processos relativos às mesmas | |
AR054581A1 (es) | Composiciones farmaceuticas que comprenden levetiracetam y proceso para su preparacion | |
WO2007042271A3 (en) | Nutraceutical composition for the treatment of muscle wasting | |
DOP2010000304A (es) | Composiciones y metodos de preparacion y uso de las mismas | |
BRPI0718523B8 (pt) | Forma de dosagem, e, método para preparar a forma de dosagem | |
BR0113494B1 (pt) | processo para a preparaÇço de uma formulaÇço sàlida herbicida, e, uso de uma formulaÇço sàlida herbicida. | |
BRPI0717219A2 (pt) | "composição imunogênica, método para tratar ou prevenir doença, e, uso de uma composição imunogênica." | |
BRPI0518334A2 (pt) | composiÇço de revestimento, mÉtodo de revestimento, revestimento, e, mÉtodo para preparar uma composiÇço de revestimento | |
BRPI0415505A (pt) | agente terapêutico para mesotelioma | |
MX2010007936A (es) | Anticuerpo anti-nr-10 y su uso. | |
BRPI0515684A (pt) | formulações de cristais injetáveis ativas de longa duração de metabólitos de estradiol, e métodos de utilização das mesmas | |
RS51563B (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING ROOSUVASTATIN CALCIUM | |
BRPI0816553A2 (pt) | "composto, composição farmcêutica, uso de uma composição, uso de um composto, e, processo para a preparação de um composto" | |
BRPI0519070A2 (pt) | composiÇço de fator de crescimento de queratinàcito liofilizada, mÉtodos para preparar um fator de crescimento de queratinàcito liofilizado, e para tratar uma doenÇa, e, kit para preparar uma composiÇço farmacÊutica aquosa | |
BRPI0912539A2 (pt) | composto, composição farmacêutica , método para tratar uma doença, e, uso do composto. | |
CL2007001838A1 (es) | Compuestos derivados de 4-oxoquinolina; composicion farmaceutica; y uso del compuesto para la produccion de un agente anti-vih. | |
BRPI0810130A8 (pt) | Composição de bebida, processo para produzir uma composição de bebida, e, uso de uma composição de bebida | |
BR112012025066A2 (pt) | mistura fluidificante para composição hidráulica | |
BR112012021418A2 (pt) | limpador de vasos sanitários e método. | |
ECSP11011286A (es) | Formulaciones orales sólidas de una pirido-pirimidinona | |
BRPI0516464B8 (pt) | método para a preparação de um produto farmacêutico | |
MX2007014963A (es) | Composicion de liberacion modificada de al menos una forma de venlafaxina. | |
BRPI0903914A2 (pt) | Uso de um composto, método para analisar a eficácia de uma composição de liberação prolongada, e, composição farmacêutica. | |
BR0314241B1 (pt) | composto, processos para a preparaÇço do mesmo e para a carbonilaÇço de um composto etilenicamente insaturado, composiÇço, e, uso de um composto ou de uma composiÇço. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B25D | Requested change of name of applicant approved |
Owner name: ONXEO S.A (FR) |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: ONXEO S.A (FR) ; VECTANS PHARMA (FR) |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B15G | Petition not considered as such [chapter 15.7 patent gazette] |
Free format text: A PETICAO 870200024848 DE 20/02/2020 DO TIPO 261 SOLICITA A CORRECAO DO DESPACHO 25.1PUBLICADO NA RPI 2497 DE 13/11/2018 COM A ALEGACAO DA TRANSFERENCIA DA TITULARIDADE TER SIDOTOTAL DO DEPOSITANTE ?ONXEO S.A? PARA O ?VECTANS PHARMA?. ENTRETANTO, COMO PODE SEROBSERVADO NA PETICAO 870180130779 DE 17/09/2018, FORAM ANEXADOS DOCUMENTOS DE CESSAOONDE COMPROVAM A CESSAO PARCIAL DOS DIREITOS DO DEPOSITANTE ?ONXEO S.A? PARA O ?VECTANSPHARMA? EVIDENCIANDO QUE NAO HA ERRO DE PUBLICACAO NA RPI. LOGO, EM VIRTUDE DO DISPOSTO NOSARTS. 218 OU 219 DA LPI (LEI 9279 / 96) DE 14/05/1996, E CONSIDERADA COMO PETICAO NAOCONHECIDA POR NAO SER A PETICAO CORRETA PARA TAL SOLICITACAO. |
|
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 30/06/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: REF. RPI 2582 DE 30/06/2020 QUANTO AO ENDERECO. |
|
B25A | Requested transfer of rights approved |
Owner name: VECTANS PHARMA (FR) |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/03/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |